<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46726">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02497950</url>
  </required_header>
  <id_info>
    <org_study_id>HeartMate 3™ Registry</org_study_id>
    <nct_id>NCT02497950</nct_id>
  </id_info>
  <brief_title>HeartMate 3 ELEVATE™</brief_title>
  <acronym>ELEVATE™</acronym>
  <official_title>Evaluating the HeartMate 3™ in a Post-Market Approval Setting: The HeartMate 3 Registry (ELEVATE™)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thoratec Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thoratec Europe Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate real-world experience of HeartMate 3 (HM3) in post-approval setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this post-market registry is to collect data and evaluate the real-world
      experience of the HeartMate 3 Left Ventricular Assist System (HM3 LVAS) in a post-approval
      setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>Up to 24 Months post-implant</time_frame>
    <description>Patients will be followed in the registry to 24 months post-implant or outcome (transplanted, explanted for recovery or expired), whichever occurs first.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EuroQoL-5D-5L (EQ-5D-5L)</measure>
    <time_frame>Baseline, 6 months, 12 months and 24 months while the patient is being supported on the HM3 LVAS</time_frame>
    <description>EQ-5D-5L measures self-rated health states/quality of life in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and 5 levels of severity (no problems, slight problems, moderate problems, severe problems, and extreme problems)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six Minute Walk Test (6MWT)</measure>
    <time_frame>Baseline, 6 months, 12 months and 24 months while the patient is being supported on the HM3 LVAS</time_frame>
    <description>The Six Minute Walk Test (6MWT) measures the distance that a patient can walk in a period of 6 minutes. The distance walked is measured in meters. This test measures the patients' functional status. The more meters a patient can walk over baseline indicates improvement in functional status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) Classification</measure>
    <time_frame>Baseline, 6 months, 12 months and 24 months while the patient is being supported on the HM3 LVAS</time_frame>
    <description>NYHA relates symptoms to every day activities and patients quality of life. Class 1 = no limitations on physical activity Class 2 - slight limitation of physical activity Class 3 - marked limitation of physical activity Class 4 = unable to carry out any physical activity without discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Frequency and incidence of pre-defined anticipated adverse event rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Malfunctions</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Frequency and incidence of device malfunction rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperations</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Frequency and incidence of reoperations after initial implant surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalizations</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Frequency and incidence of rehospitalizations after initial discharge from implant surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Heart Failure</condition>
  <condition>Cardiovascular Disease</condition>
  <condition>Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>HeartMate 3</arm_group_label>
    <description>This registry will include all patients that receive the HM3 LVAS in the post-market setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartMate 3</intervention_name>
    <description>Any patient that is determined to meet the HM3 commercially approved labelling indication and that is implanted with the HM3</description>
    <arm_group_label>HeartMate 3</arm_group_label>
    <other_name>HM3</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients that receive the HeartMate 3 LVAS in the post-approval setting
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion:

          1. Patient consented to registry data collection

          2. Patient has met the HeartMate 3 commercially approved labeling indication and is
             implanted with the HM3.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Damme, BSN, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Thoratec, LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Damme, BSN, MPH</last_name>
    <email>ldamme@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AJH - Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roxana Moayedifar</last_name>
      <email>roxana.moayedifar@meduniwien.at</email>
    </contact>
    <investigator>
      <last_name>Daniel Zimpher, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine (IKEM)</name>
      <address>
        <city>Prague</city>
        <zip>4</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Turkova</last_name>
      <email>jana.turkova@ikem.cz</email>
    </contact>
    <investigator>
      <last_name>Ivan Netuka, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lene Larson</last_name>
      <email>lene.larsen02@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Finn Gustafsson, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Berg</last_name>
      <email>thberg@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Goetzenich, PD,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäßklinik Bad Neustadt a d Saale</name>
      <address>
        <city>Bad Neustadt a d Saale</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrin Vollert</last_name>
      <email>katrin.vollert@herzchirurgie.de</email>
    </contact>
    <investigator>
      <last_name>Anno Diegeler, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz-und Diabetes Zentrum NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Schoenbrodt</last_name>
      <email>aschoenbrodt@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Michiel Morshuis, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schüchtermann Klinik</name>
      <address>
        <city>Bad Rothenfelde</city>
        <zip>49214</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgit Wichter</last_name>
      <email>bwichter@schuechtermann-klinik.de</email>
    </contact>
    <investigator>
      <last_name>Sebastian Schulte Eistrup, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Detschades</last_name>
      <email>detschades@dhzb.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Krabatsch, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Einrichtungen der Universitat Dusseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Najla Sadat</last_name>
      <email>najla.sadat@med.uni-dusseldorf.de</email>
    </contact>
    <investigator>
      <last_name>Diyar Saeed, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitäts-Herzzentrum Freiburg</name>
      <address>
        <city>Freiberg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Lechner</last_name>
      <email>gabriele.lechner@universitaets-herzzentrum.de</email>
    </contact>
    <investigator>
      <last_name>Michael Berchtold-Herz, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirsten Stelter</last_name>
      <email>stelter.kirsten@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Jan D Schmitto, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07740</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Rosenkranz</last_name>
      <email>evelyn.rosenkranz@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Gloria Farber, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>04280</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Schuetz</last_name>
      <email>nicole.schuetz@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Jens Garbade, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig Holstein</name>
      <address>
        <city>Lubeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Karluss, Dr</last_name>
      <email>antje.karluss@uksh.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Klotz, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Otto-von-Guericke-Universitat Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Staak, MD</last_name>
      <email>thorsten.staack@med.ovgu.de</email>
    </contact>
    <investigator>
      <last_name>Hassina Baraki, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tubingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Schibilsky, Dr,med</last_name>
      <email>david.schibilsky@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Christian Schlensak, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Kogan</last_name>
      <email>diana.kogan@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Jacob Lavee, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Pieri</last_name>
      <email>pieri.marina@hrs.it</email>
    </contact>
    <investigator>
      <last_name>Frederico Pappalardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Az. Osp. San Camillo Fortanini</name>
      <address>
        <city>Roma</city>
        <zip>00152</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Montalto, MD</last_name>
      <email>andrea.montalto@libero.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Musumeci, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Maggiore di Verona Borgo Trento</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Forni, MD</last_name>
      <email>alberto.forni@ospedaleuniverona.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Faggian, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Research Center for Cardiac Surgery</name>
      <address>
        <city>Astana</city>
        <zip>010000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bagdat Abdirova</last_name>
      <email>bagdat.du@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yuriy Pya, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Thoraxcenter</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasper Brugts, MD</last_name>
      <email>j.brugts@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Olivier Manintveld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faiz Ramjankhan, MD</last_name>
      <email>f.ramjankhan@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Faiz Ramjankhan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warsaw Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>02-943</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pawel Litwinski, Dr,med</last_name>
    </contact>
    <investigator>
      <last_name>Mariusz Kusmierczyk, Prof,Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Heart Centre Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ka Lee Kerk</last_name>
      <email>kerk.ka.lee@nhcs.com.sg</email>
    </contact>
    <investigator>
      <last_name>Cumaraswamy Sivathasan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sern Lim, Dr</last_name>
      <email>sern.lim@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Sern Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Parminder Chaggar, Dr.</last_name>
      <email>pchaggar@doctors.org.uk</email>
    </contact>
    <investigator>
      <last_name>Steven Shaw, Dr,med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Kazakhstan</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Singapore</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 19, 2016</lastchanged_date>
  <firstreceived_date>July 3, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HeartMate 3</keyword>
  <keyword>LVAS</keyword>
  <keyword>LVAD</keyword>
  <keyword>Heart-assist devices</keyword>
  <keyword>Thoratec Corporation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
